Logo image of DVA

DAVITA INC (DVA) Stock Price, Quote, News and Overview

NYSE:DVA - New York Stock Exchange, Inc. - US23918K1088 - Common Stock - Currency: USD

176.86  -0.49 (-0.28%)

After market: 176.86 0 (0%)

DVA Quote, Performance and Key Statistics

DAVITA INC

NYSE:DVA (2/5/2025, 8:04:00 PM)

After market: 176.86 0 (0%)

176.86

-0.49 (-0.28%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High179.6
52 Week Low108.76
Market Cap14.50B
Shares82.00M
Float42.16M
Yearly Dividend0.01
Dividend YieldN/A
PE19.92
Fwd PE15.67
Earnings (Next)02-13 2025-02-13/amc
IPO10-31 1995-10-31


DVA short term performance overview.The bars show the price performance of DVA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20 25

DVA long term performance overview.The bars show the price performance of DVA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of DVA is 176.86 USD. In the past month the price increased by 16.72%. In the past year, price increased by 60.99%.

DAVITA INC / DVA Daily stock chart

DVA Latest News, Press Releases and Analysis

News Image
7 days ago - DaVita

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

/PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday,...

News Image
22 days ago - DaVita

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

/PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since...

News Image
a month ago - DaVita

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

/PRNewswire/ -- DaVita, a comprehensive kidney care provider, has activated its emergency response plan as devastating wildfires spread across Southern...

News Image
2 months ago - Investor's Business Daily

DaVita Stock Sees Improved Relative Strength Rating

DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72.

DVA Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
CI THE CIGNA GROUP 10.73 81.58B
CVS CVS HEALTH CORP 8.77 70.08B
LH LABCORP HOLDINGS INC 17.34 20.91B
DGX QUEST DIAGNOSTICS INC 18.28 18.40B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 177.13 14.50B
FMS FRESENIUS MEDICAL CARE-ADR 14.8 14.42B
HIMS HIMS & HERS HEALTH INC 95.91 9.22B
CHE CHEMED CORP 24.57 8.43B
CRVL CORVEL CORP 27.27 6.60B
GH GUARDANT HEALTH INC N/A 5.88B
OPCH OPTION CARE HEALTH INC 26.32 5.33B
RDNT RADNET INC 110.41 4.99B

About DVA

Company Profile

DVA logo image DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 70,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Company Info

DAVITA INC

2000 16th St

Denver COLORADO 80202 US

CEO: Javier J. Rodriguez

Employees: 70000

Company Website: https://www.davita.com/

Investor Relations: https://investors.davita.com

Phone: 13105362668

DVA FAQ

What is the stock price of DVA?

The current stock price of DVA is 176.86 USD.


What is the symbol for DAVITA INC stock?

The exchange symbol of DAVITA INC is DVA and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is DVA stock listed?

DVA stock is listed on the New York Stock Exchange, Inc. exchange.


Is DVA a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for DVA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of DVA.


Does DVA stock pay dividends?

DVA does not pay a dividend.


When does DVA stock report earnings?

DVA will report earnings on 2025-02-13, after the market close.


What is the Price/Earnings (PE) ratio of DVA?

The PE ratio for DVA is 19.92. This is based on the reported non-GAAP earnings per share of 8.88 and the current share price of 176.86 USD.


What is the Short Interest ratio of DVA stock?

The outstanding short interest for DVA is 11.02% of its float.


DVA Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to DVA. When comparing the yearly performance of all stocks, DVA is one of the better performing stocks in the market, outperforming 91.09% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

DVA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to DVA. While DVA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DVA Financial Highlights

Over the last trailing twelve months DVA reported a non-GAAP Earnings per Share(EPS) of 8.88. The EPS increased by 39.4% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.53%
ROA 4.73%
ROE 214.03%
Debt/Equity 23.95
Chartmill High Growth Momentum
EPS Q2Q%-4.58%
Sales Q2Q%4.56%
EPS 1Y (TTM)39.4%
Revenue 1Y (TTM)6.34%

DVA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 53% to DVA. The Buy consensus is the average rating of analysts ratings from 16 analysts.

For the next year, analysts expect an EPS growth of 32.76% and a revenue growth 6.32% for DVA


Ownership
Inst Owners50.63%
Ins Owners4.09%
Short Float %11.02%
Short Ratio7.2
Analysts
Analysts52.5
Price Target162.99 (-7.84%)
EPS Next Y32.76%
Revenue Next Year6.32%